ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 897,37
-0,12%
Dow Jones
44 850,35
0,31%
DAX
21 430,58
0,71%
Brent Oil
76,61
0,45%
Bitcoin
101 038,36
-1,01%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amryt Pharma PLC (AMYT)

  7. Amryt Pharma PLC (AMYT) Actualités

AMYT

Amryt Pharma (AMYT)

Amryt Pharma PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMYT
DateHeureSourceTitreSymboleSociété
18/04/202323h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
18/04/202322h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
12/04/202323h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
12/04/202314h21Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AMYTAmryt Pharma PLC
12/04/202313h58PR Newswire (US)Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
11/04/202315h00GlobeNewswire Inc.2022 for Chiesi: The Group’s international growth continuesNASDAQ:AMYTAmryt Pharma PLC
07/11/202204h35TipRanksSVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
04/11/202219h55TipRanksAmryt Pharma (AMYT) Receives a Buy from Maxim GroupNASDAQ:AMYTAmryt Pharma PLC
04/11/202211h25TipRanksAmryt Pharma (AMYT) Receives a Buy from H.C. WainwrightNASDAQ:AMYTAmryt Pharma PLC
19/09/202212h25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
08/08/202214h27TipRanksH.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
05/08/202219h25TipRanksMaxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
14/07/202213h49Dow Jones NewsAmryt Gets FDA Orphan Designation for Mycapssa in Carcinoid SyndromeNASDAQ:AMYTAmryt Pharma PLC
26/06/202209h39TipRanksSVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
24/06/202213h54Dow Jones NewsAmryt to Pursue Formal FDA Resolution for Oleogel-S10NASDAQ:AMYTAmryt Pharma PLC
23/05/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMYTAmryt Pharma PLC
20/05/202223h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
11/05/202223h23Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:AMYTAmryt Pharma PLC
06/05/202222h08TipRanksAmryt Pharma (AMYT) Gets a Buy Rating from Maxim GroupNASDAQ:AMYTAmryt Pharma PLC
05/05/202212h28TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
04/05/202214h35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AMYTAmryt Pharma PLC
29/04/202221h15Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AMYTAmryt Pharma PLC
09/03/202212h21TipRanksH.C. Wainwright Thinks Amryt Pharma’s Stock is Going to RecoverNASDAQ:AMYTAmryt Pharma PLC
28/02/202216h12Dow Jones NewsAmryt Pharma Shares Tumble After FDA Rejects Oleogel-S10 ApplicationNASDAQ:AMYTAmryt Pharma PLC
14/02/202215h00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AMYTAmryt Pharma PLC
12/01/202217h10TipRanksMaxim Group Thinks Amryt Pharma’s Stock is Going to RecoverNASDAQ:AMYTAmryt Pharma PLC
24/11/202112h18TipRanksAmryt Pharma (AMYT) Gets a Buy Rating from H.C. WainwrightNASDAQ:AMYTAmryt Pharma PLC
23/11/202117h35TipRanksLeerink Partners Sticks to Their Buy Rating for Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
06/08/202120h50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMYTAmryt Pharma PLC
15/06/202112h29Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-4)NASDAQ:AMYTAmryt Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:AMYT

Dernières Valeurs Consultées

AQSE
SPY5.GB
SPDR S&P 500 UCITS ETF
BIT
F14361
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés